Estonia, Oct. 14 -- Estonia based Roche Eesti Osauhing has secured contract from sihtasutus Tartu Ulikooli Kliinikum for Pharmaceutical Products - drug pertuzumab Trastuzumab L01xy01 subcutaneous solution for injection. The value of the contract is worth 398183162 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....